Journal of Clinical Oncology

Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?

V Vit Prochazka V Veronika Hanackova (5Faculty of Medicine and Dentistry, Palacky University and University Hospital, Department of Haemato-Oncology, Olomouc, Czech Republic) L Lenka Henzlová (Vít Procházka, MD, PhD and Veronika Hanáčková, MD, Department of Hemato-Oncology, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic; and Lenka Henzlová, MD, PhD and Jaroslav Ptáček, PhD, Department of Nuclear Medicine, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic) J Jaroslav Ptáček (Vít Procházka, MD, PhD and Veronika Hanáčková, MD, Department of Hemato-Oncology, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic; and Lenka Henzlová, MD, PhD and Jaroslav Ptáček, PhD, Department of Nuclear Medicine, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 11
Published April 10, 2025
Pages 1395-1396
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (4)

V

Vit Prochazka

V

Veronika Hanackova

5Faculty of Medicine and Dentistry, Palacky University and University Hospital, Department of Haemato-Oncology, Olomouc, Czech Republic

L

Lenka Henzlová

Vít Procházka, MD, PhD and Veronika Hanáčková, MD, Department of Hemato-Oncology, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic; and Lenka Henzlová, MD, PhD and Jaroslav Ptáček, PhD, Department of Nuclear Medicine, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic

J

Jaroslav Ptáček

Vít Procházka, MD, PhD and Veronika Hanáčková, MD, Department of Hemato-Oncology, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic; and Lenka Henzlová, MD, PhD and Jaroslav Ptáček, PhD, Department of Nuclear Medicine, Faculty of Medicine and Dentistry Palacky University and University Hospital Olomouc, Olomouc, Czech Republic

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001